Accreditation Information

CPE

ACPEThe University of North Texas Health Science Center is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This knowledge-based activity has been assigned UAN 0845-0000-17-030-L01-P and will award 1.00 contact hour (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

Statements of participation will indicate hours and CEUs based on participation and will be issued online at the conclusion of the activity. Successful completion includes signing in at registration, attending the entire session for which credit is claimed, completing the activity evaluation and requesting credit online at conclusion of the activity. Credit will be uploaded to CPE Monitor, and participants may print a statement of credit or transcript from their NABP e-profile. UNTHSC complies with the Accreditation Standards for Continuing Pharmacy Education.

CNE

UNT Health Science Center is approved by the California Board of Registered Nursing, Provider # 16274. This activity is approved for 1.20 Contact Hours.

UNTHSC

The University of North Texas Health Science Center certifies this activity for 1.00 hour of participation.

Physicians

The University of North Texas Health Science Center is accredited by the American Osteopathic Association to award continuing medical education to physicians.

The University of North Texas Health Science Center has requested that the AOA Council on Continuing Medical Education approve this program for 1.00 hour of AOA Category 1A CME credits. Approval is currently pending.

The University of North Texas Health Science Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of North Texas Health Science Center designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of North Texas Health Science Center presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

ACGME Competencies

  • Medical knowledge

IOM Competencies

  • Employ evidence-based practice

Objectives

  • Discuss the distinct molecular nature of BRCA1 and BRCA2 mutant tumors.
  • Describe synthetic lethality as a therapeutic approach
  • Discuss the utility of PARP inhibitors

Target Audience

This activity was planned to address the educational needs of physicians, physician assistants, nurse practitioners, nurses and pharmacists.

Faculty Disclosure

Alan Ashworth has made the following disclosures:

Dr. Ashworth has received research funding from SPARC/Sun Pharma.

Dr. Ashworth is a paid consultant for Genetech, AtlasMDX, Third Rock Ventures, Pfizer, Sun Pharma, Bluestar

Dr. Ashworth received stock options from Tango Therapeutics

Dr. Ashworth receives royalites from AstraZeneca.

Activity content will be peer reviewed prior to the activity to ensure there is no apparent bias.

The UNT Health Science Center Professional and Continuing Education staff and Grand Rounds Planning Committee have nothing to disclose.